Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Goldstein

Showing results (121-130 of 517) with videos related to

Pageof 52
Sort By:
Pain|July 5, 2021
Effects of combined chemotherapy and anti-programmed cell death protein 1 treatment on peripheral neuropathy and neuroinflammation in miceLital Livni, Brooke A Keating, Nathan T Fiore, et al.
Asia-Pacific Journal of Clinical Oncology|November 7, 2017
Predictors of care for patients with cancer of unknown primary site in three Australian hospitalsSimon Y S Tan, Siobhan O'Neill, David Goldstein, et al.
Clinical Colorectal Cancer|August 8, 2007
Modification of leucovorin dose within a simplified FOLFOX regimen improves tolerability without compromising efficacyStephen Clarke, David Goldstein, Paul Mitchell, et al.
Cancer Letters|November 17, 2015
Key role of pancreatic stellate cells in pancreatic cancerSrinivasa P Pothula, Zhihong Xu, David Goldstein, et al.
Oncotarget|February 25, 2016
Overcoming resistance of targeted EGFR monotherapy by inhibition of STAT3 escape pathway in soft tissue sarcomaXiaochun Wang, David Goldstein, Philip J Crowe, et al.
JCO Global Oncology|February 22, 2023
ASCO's Leadership Development Program: Focusing on the Next Generation of Leaders in Asia PacificRoselle B de Guzman, Melvin L K Chua, David Goldstein, et al.
Prehospital Emergency Care|September 10, 2021
Prehospital Initiation of Buprenorphine Treatment for Opioid Use Disorder by ParamedicsH Gene Hern, David Goldstein, M Kalmin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2009
Antitumor effect of somatostatin analogs in neuroendocrine tumorsYu Jo Chua, Michael Michael, John R Zalcberg, et al.
Cancers|June 2, 2021
Does the Microenvironment Hold the Hidden Key for Functional Precision Medicine in Pancreatic Cancer?John Kokkinos, Anya Jensen, George Sharbeen, et al.
BJU International|March 10, 2007
Erlotinib (OSI-774)-induced inhibition of transitional cell carcinoma of bladder cell line growth is enhanced by interferon-alphaJia-Lin Yang, Xian-Jun Qu, Vanessa M Hayes, et al.
Pageof 52

Showing results (121-130 of 517) with videos related to

Sort By:
Pageof 52
Pain|July 5, 2021
Effects of combined chemotherapy and anti-programmed cell death protein 1 treatment on peripheral neuropathy and neuroinflammation in miceLital Livni, Brooke A Keating, Nathan T Fiore, et al.
Asia-Pacific Journal of Clinical Oncology|November 7, 2017
Predictors of care for patients with cancer of unknown primary site in three Australian hospitalsSimon Y S Tan, Siobhan O'Neill, David Goldstein, et al.
Clinical Colorectal Cancer|August 8, 2007
Modification of leucovorin dose within a simplified FOLFOX regimen improves tolerability without compromising efficacyStephen Clarke, David Goldstein, Paul Mitchell, et al.
Cancer Letters|November 17, 2015
Key role of pancreatic stellate cells in pancreatic cancerSrinivasa P Pothula, Zhihong Xu, David Goldstein, et al.
Oncotarget|February 25, 2016
Overcoming resistance of targeted EGFR monotherapy by inhibition of STAT3 escape pathway in soft tissue sarcomaXiaochun Wang, David Goldstein, Philip J Crowe, et al.
JCO Global Oncology|February 22, 2023
ASCO's Leadership Development Program: Focusing on the Next Generation of Leaders in Asia PacificRoselle B de Guzman, Melvin L K Chua, David Goldstein, et al.
Prehospital Emergency Care|September 10, 2021
Prehospital Initiation of Buprenorphine Treatment for Opioid Use Disorder by ParamedicsH Gene Hern, David Goldstein, M Kalmin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2009
Antitumor effect of somatostatin analogs in neuroendocrine tumorsYu Jo Chua, Michael Michael, John R Zalcberg, et al.
Cancers|June 2, 2021
Does the Microenvironment Hold the Hidden Key for Functional Precision Medicine in Pancreatic Cancer?John Kokkinos, Anya Jensen, George Sharbeen, et al.
BJU International|March 10, 2007
Erlotinib (OSI-774)-induced inhibition of transitional cell carcinoma of bladder cell line growth is enhanced by interferon-alphaJia-Lin Yang, Xian-Jun Qu, Vanessa M Hayes, et al.
Pageof 52